Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VIBATIV | Cumberland Pharmaceuticals | N-022110 RX | 2009-09-11 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
telavancin hydrochloride | New Drug Application | 2012-12-12 |
vibativ | New Drug Application | 2023-11-10 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
pneumonia | EFO_0003106 | D011014 | J18 |
bacterial infections | — | D001424 | A49 |
infectious skin diseases | — | D012874 | — |
streptococcal infections | EFO_1001476 | D013290 | — |
staphylococcal infections | — | D013203 | A49.01 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Telavancin Hydrochloride, Vibativ, Cumberland | |||
7531623 | 2027-01-01 | DP |
Code | Description |
---|---|
J3095 | Injection, telavancin, 10 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 1 | — | 1 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | 1 | — | 1 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sepsis | D018805 | EFO_0001420 | A41.9 | — | 1 | — | — | — | 1 |
Infections | D007239 | EFO_0000544 | — | — | 1 | — | — | — | 1 |
Communicable diseases | D003141 | — | — | — | 1 | — | — | — | 1 |
Bacteremia | D016470 | EFO_0003033 | R78.81 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Telavancin |
INN | telavancin |
Description | Telavancin is a glycopeptide that is vancomycin substituted at position N-3'' by a 2-(decylamino)ethyl group and at position C-29 by a (phosphonomethyl)aminomethyl group. Used as its hydrochloride salt for treatment of adults with complicated skin and skin structure infections caused by bacteria. It has a role as an antibacterial drug and an antimicrobial agent. It is functionally related to a vancomycin. |
Classification | Unknown |
Drug class | vancomycin-related compounds |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O |
PDB | — |
CAS-ID | 372151-71-8 |
RxCUI | — |
ChEMBL ID | CHEMBL507870 |
ChEBI ID | 71229 |
PubChem CID | 3081362 |
DrugBank | DB06402 |
UNII ID | XK134822Z0 (ChemIDplus, GSRS) |